image

The best stocks to buy since 1993

Latest issue now available

Regenersis - Step up in cost base to accelerate growth

April 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RGS
  • Price:
  • 358p
Regenersis’ interims showed sales up 11% to £99.7m (+17% constant currency) but pretax profit was flat at £5.6m mainly due to a £1.2m step up in the cost base. Stripping that out, there was 22% underlying  growth in pretax profit. The core repair side generated a same-again £4.2m operating profit on sales up 10% to £83.9m with growth in the emerging market operations continuing.  The flat divisional profit belies the fact that Regenesis’ repair side is extremely busy. Last year it won 10 new contracts in H2 –with an annual value of £70m - but when it takes new work on it usually incurs a period of losses before the contracts turn profitable. Interestingly, chairman Matthew Peacock  points to a strong shift to working for the netwo ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe